Effectiveness of third-generation cephalosporins or piperacillin compared with cefepime or carbapenems for severe infections caused by wild-type AmpC β-lactamase-producing Enterobacterales: A multi-centre retrospective propensity-weighted study
Alexis Maillard, Tristan Delory, Juliette Bernier, Antoine Villa, Khalil Chaïbi, L. Escaut, Adrien Contejean, Béatrice Berçot, J. Robert, Fatma El Alaoui, Jacques Tankovic, Hélène Poupet, Gaëlle Cuzon, Matthieu Lafaurie, Laure Surgers, Adrien Joseph, Olivier Paccoud, Jean‐Michel Molina, Alexandre Bleibtreu
Topics & Concepts
CefepimePiperacillin/tazobactamPiperacillinMedicineCephalosporinTazobactamInternal medicinePneumoniaCarbapenemClinical endpointHazard ratioConfidence intervalAntibioticsMicrobiologyRandomized controlled trialImipenemBiologyAntibiotic resistancePseudomonas aeruginosaBacteriaGeneticsAntibiotic Resistance in BacteriaAntibiotics Pharmacokinetics and EfficacyNosocomial Infections in ICU